Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5 year follow-up.
Scher
H I
HI
D000971:Antineoplastic Combined Chemotherapy Protocols; D002945:Cisplatin; D004317:Doxorubicin; D005500:Follow-Up Studies; D006801:Humans; D008727:Methotrexate; D009361:Neoplasm Invasiveness; D011379:Prognosis; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D014747:Vinblastine
D014747:Vinblastine; D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate